These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 30048639)

  • 1. Intact transferrin and total plasma glycoprofiling for diagnosis and therapy monitoring in phosphoglucomutase-I deficiency.
    Abu Bakar N; Voermans NC; Marquardt T; Thiel C; Janssen MCH; Hansikova H; Crushell E; Sykut-Cegielska J; Bowling F; MØrkrid L; Vissing J; Morava E; van Scherpenzeel M; Lefeber DJ
    Transl Res; 2018 Sep; 199():62-76. PubMed ID: 30048639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A new D-galactose treatment monitoring index for PGM1-CDG.
    Perales-Clemente E; Liedtke K; Studinski A; Radenkovic S; Gavrilov D; Oglesbee D; Matern D; Rinaldo P; Tortorelli S; Morava E; Raymond K
    J Inherit Metab Dis; 2021 Sep; 44(5):1263-1271. PubMed ID: 34043239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral D-galactose supplementation in PGM1-CDG.
    Wong SY; Gadomski T; van Scherpenzeel M; Honzik T; Hansikova H; Holmefjord KSB; Mork M; Bowling F; Sykut-Cegielska J; Koch D; Hertecant J; Preston G; Jaeken J; Peeters N; Perez S; Nguyen DD; Crivelly K; Emmerzaal T; Gibson KM; Raymond K; Abu Bakar N; Foulquier F; Poschet G; Ackermann AM; He M; Lefeber DJ; Thiel C; Kozicz T; Morava E
    Genet Med; 2017 Nov; 19(11):1226-1235. PubMed ID: 28617415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.
    van Scherpenzeel M; Steenbergen G; Morava E; Wevers RA; Lefeber DJ
    Transl Res; 2015 Dec; 166(6):639-649.e1. PubMed ID: 26307094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.
    Altassan R; Radenkovic S; Edmondson AC; Barone R; Brasil S; Cechova A; Coman D; Donoghue S; Falkenstein K; Ferreira V; Ferreira C; Fiumara A; Francisco R; Freeze H; Grunewald S; Honzik T; Jaeken J; Krasnewich D; Lam C; Lee J; Lefeber D; Marques-da-Silva D; Pascoal C; Quelhas D; Raymond KM; Rymen D; Seroczynska M; Serrano M; Sykut-Cegielska J; Thiel C; Tort F; Vals MA; Videira P; Voermans N; Witters P; Morava E
    J Inherit Metab Dis; 2021 Jan; 44(1):148-163. PubMed ID: 32681750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series.
    Radenkovic S; Johnsen C; Schulze A; Lail G; Guilder L; Schwartz K; Schultz M; Mercimek-Andrews S; Boyer S; Morava E
    Ther Adv Rare Dis; 2023; 4():26330040221150269. PubMed ID: 37181075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots.
    Conte F; Morava E; Bakar NA; Wortmann SB; Poerink AJ; Grunewald S; Crushell E; Al-Gazali L; de Vries MC; Mørkrid L; Hertecant J; Brocke Holmefjord KS; Kronn D; Feigenbaum A; Fingerhut R; Wong SY; van Scherpenzeel M; Voermans NC; Lefeber DJ
    Mol Genet Metab; 2020; 131(1-2):135-146. PubMed ID: 33342467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG.
    Radenkovic S; Bird MJ; Emmerzaal TL; Wong SY; Felgueira C; Stiers KM; Sabbagh L; Himmelreich N; Poschet G; Windmolders P; Verheijen J; Witters P; Altassan R; Honzik T; Eminoglu TF; James PM; Edmondson AC; Hertecant J; Kozicz T; Thiel C; Vermeersch P; Cassiman D; Beamer L; Morava E; Ghesquière B
    Am J Hum Genet; 2019 May; 104(5):835-846. PubMed ID: 30982613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple phenotypes in phosphoglucomutase 1 deficiency.
    Tegtmeyer LC; Rust S; van Scherpenzeel M; Ng BG; Losfeld ME; Timal S; Raymond K; He P; Ichikawa M; Veltman J; Huijben K; Shin YS; Sharma V; Adamowicz M; Lammens M; Reunert J; Witten A; Schrapers E; Matthijs G; Jaeken J; Rymen D; Stojkovic T; Laforêt P; Petit F; Aumaître O; Czarnowska E; Piraud M; Podskarbi T; Stanley CA; Matalon R; Burda P; Seyyedi S; Debus V; Socha P; Sykut-Cegielska J; van Spronsen F; de Meirleir L; Vajro P; DeClue T; Ficicioglu C; Wada Y; Wevers RA; Vanderschaeghe D; Callewaert N; Fingerhut R; van Schaftingen E; Freeze HH; Morava E; Lefeber DJ; Marquardt T
    N Engl J Med; 2014 Feb; 370(6):533-42. PubMed ID: 24499211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG.
    Morava E
    Mol Genet Metab; 2014 Aug; 112(4):275-9. PubMed ID: 24997537
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galactose Supplementation in Patients With TMEM165-CDG Rescues the Glycosylation Defects.
    Morelle W; Potelle S; Witters P; Wong S; Climer L; Lupashin V; Matthijs G; Gadomski T; Jaeken J; Cassiman D; Morava E; Foulquier F
    J Clin Endocrinol Metab; 2017 Apr; 102(4):1375-1386. PubMed ID: 28323990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the Phenotype and Assessing Severity in Phosphoglucomutase-1 Deficiency.
    Wong SY; Beamer LJ; Gadomski T; Honzik T; Mohamed M; Wortmann SB; Brocke Holmefjord KS; Mork M; Bowling F; Sykut-Cegielska J; Koch D; Ackermann A; Stanley CA; Rymen D; Zeharia A; Al-Sayed M; Marquardt T; Jaeken J; Lefeber D; Conrad DF; Kozicz T; Morava E
    J Pediatr; 2016 Aug; 175():130-136.e8. PubMed ID: 27206562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Limitations of galactose therapy in phosphoglucomutase 1 deficiency.
    Nolting K; Park JH; Tegtmeyer LC; Zühlsdorf A; Grüneberg M; Rust S; Reunert J; Du Chesne I; Debus V; Schulze-Bahr E; Baxter RC; Wada Y; Thiel C; van Schaftingen E; Fingerhut R; Marquardt T
    Mol Genet Metab Rep; 2017 Dec; 13():33-40. PubMed ID: 28794993
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGM1 deficiency: Substrate use during exercise and effect of treatment with galactose.
    Voermans NC; Preisler N; Madsen KL; Janssen MC; Kusters B; Abu Bakar N; Conte F; Lamberti VM; Nusman F; van Engelen BG; van Scherpenzeel M; Vissing J; Lefeber DJ
    Neuromuscul Disord; 2017 Apr; 27(4):370-376. PubMed ID: 28190645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Clinical Sensitivity and Specificity of Plasma Protein
    Chen J; Li X; Edmondson A; Meyers GD; Izumi K; Ackermann AM; Morava E; Ficicioglu C; Bennett MJ; He M
    Clin Chem; 2019 May; 65(5):653-663. PubMed ID: 30770376
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Partial correction of neutrophil dysfunction by oral galactose therapy in glycogen storage disease type Ib.
    Letkemann R; Wittkowski H; Antonopoulos A; Podskabi T; Haslam SM; Föll D; Dell A; Marquardt T
    Int Immunopharmacol; 2017 Mar; 44():216-225. PubMed ID: 28126686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PGM1 deficiency diagnosed during an endocrine work-up of low IGF-1 mediated growth failure.
    Zeevaert R; Scalais E; Muino Mosquera L; De Meirleir L; De Beaufort C; Witsch M; Jaeken J; De Schepper J
    Acta Clin Belg; 2016 Dec; 71(6):435-437. PubMed ID: 27351072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.
    Ondruskova N; Honzik T; Vondrackova A; Tesarova M; Zeman J; Hansikova H
    Neuro Endocrinol Lett; 2014; 35(2):137-41. PubMed ID: 24878975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A combined defect in the biosynthesis of N- and O-glycans in patients with cutis laxa and neurological involvement: the biochemical characteristics.
    Wopereis S; Morava E; Grünewald S; Mills PB; Winchester BG; Clayton P; Coucke P; Huijben KM; Wevers RA
    Biochim Biophys Acta; 2005 Jun; 1741(1-2):156-64. PubMed ID: 15955459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and biochemical improvement with galactose supplementation in SLC35A2-CDG.
    Witters P; Tahata S; Barone R; Õunap K; Salvarinova R; Grønborg S; Hoganson G; Scaglia F; Lewis AM; Mori M; Sykut-Cegielska J; Edmondson A; He M; Morava E
    Genet Med; 2020 Jun; 22(6):1102-1107. PubMed ID: 32103184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.